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INTRODUCTION 
Chronic wounds are characterised by aberrations 
in normal wound healing processes and a delay 
in wound healing (1). Often, when wounds fail 
to heal, epithelial cells become unresponsive to 
growth factor signals and proliferate around the 
wound margins, without migrating over the 
wounds surface (2). 
Larval Debridement Therapy (LDT) or Maggot 
Therapy (MT) for chronic and necrotic wounds, 
including pressure sores (3) and diabetic foot 
ulcers (4), uses the medicinal maggot Lucilia 
sericata, and has been shown to debride wounds 
considerably quicker than other conventional 
treatments, including hydrogel therapy (5).  
In addition, MT has recently been shown to 
have a wide range of positive healing effects in 
vivo and in vitro: Clinically, several reports 
claim that there is an improved healing outcome 
following treatments of patients with MT (6-8).  
To date, however, there has been only one major 
clinical trial which examined wound healing, 
and found there was no significant improvement 
in wound healing for patients following MT as 
opposed to conventional treatment (9). Future 
clinical trials, better designed to focus on 
healing rather than debridement as an endpoint 
(10), are warranted. 
In vitro, scientists have uncovered several 
enhanced effects of maggot secretions on wound 
healing pathways, including promotion of 
angiogenesis (8, 11-13) Zhang et al, 2010, 
2017)), increasing microvascular epidermal cell 
migration (14), up regulating expression of 
wound healing related genes, including 
epidermal growth factor (EGF), transforming 
growth factor (TGF)-β1 and vascular endothelial 
growth factor (VEGF)-A (15).  
Proteome sequencing has also shown the 
presence of 5 potentially therapeutic peptidases 
secreted by L. sericata (16), which have been 
suggested to contribute to wound healing by 
promoting remodelling of the extracellular 
matrix, maintaining cellular morphology within 
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the wound, promoting fibroblast migration (17) 
and promoting hepatocyte growth factor (HGF) 
secretion in fibroblasts (18). 
Previous studies have attributed effects on 
fibroblaststo components present in larval 
extracts (19). More recently, reports suggested 
that maggot serine proteases, trypsin-like, 
chymotrypsin-like proteases and 
metalloproteinases present in externalised 
secretions were responsible for enhancing 
fibroblast migration (20-22).  However, 
investigations into the mechanisms of fibroblast 
motility for wound healing have shown that 
several growth factors, including EGF, pDGF-
BB and TGF Beta are vital for fibroblast 
migration (23-25). Recently, a report by Li et 
al., (2015) showed that promotion of wound 
healing appears to be mediated via a TGF-β 
signalling pathway, which was activated in the 
presence of maggot extracts (26).  
Maggots themselves grow into different 
developmental stages as they debride a wound, 
from tiny L1 stages, moulting twice on the 
wound to give rise to the final L3 stage. Larval 
growth of insects is still a puzzle, but is believed 
to be under environmental and physiological 
control, and dependent on the secretion of insect 
growth hormones (27). Conserved proteins 
showing homology to human growth factors 
have been demonstrated in a range of 
invertebrates and insects (28), including several 
in Drosophila (29). Decapentaplegic (Dpp), 
insulin-like peptides regulating the insulin 
receptor-signalling pathway (30), similar to the 
insulin receptor signalling-pathway in 
mammals, have been implicated in regulating 
growth and development in Drosophila (31). 
There have however no published reports to date 
of the presence of any human growth 
homologues in the ES of medicinal maggots.  
Our study aimed to investigate if components of 
L. sericata nES, other than endogenous 
proteases, played a role in fibroblast migration, 
and in light of the above, to determine if we 
could detect the presence of other proteinaceous 
factors which could be contributing to the 
observed enhancement of wound healing 
following treatment with LDT.  
METHODS 
Collection of L. Sericata Secretions 
Sterilised late larval stage 2/3 L. sericata larvae 
were supplied by Biomonde®, Bridgend, UK 
with nES collected as previously described (32). 
Briefly, larvae were incubated with 200 µl of 
sterile ultrapure water per gram of larvae in 
darkness, for one hour, at 30
O
C.  Secretions 
were then collected, centrifuged at 10,000 x g 
for 5 minutes and the supernatant retained for 
testing. Where specified, PI cocktail (AEBSF at 
104 mM, Aprotinin at 80 μM, Bestatin at 4 mM, 
E-64 at 1.4 mM, Leupeptin at 2 mM and 
Pepstatin A at 1.5 mM, Sigma Aldrich, Dorset, 
UK) was added to maggot ES at a concentration 
of 1µl per 1000 µl of nES. Following collection 
of nES, larvae were frozen to -20
O
C. 
Preparation of L. Sericatalysate 
For lysate preparation, frozen larvae were 
thawed at 37
O
C and 2 g of maggots placed in a 
glass homogeniser with 2 ml of RIPA buffer 
(Sigma Aldrich) and 20 µl of PI cocktail. 
Maggots were fully homogenized by hand and 
incubated at 4
O
C for 5 minutes before being 
centrifuged at 6,000 rpm for 15 minutes at 4
O
C. 
The supernatant was collected, passed through a 
0.2 µm filter to remove any particulates and 
stored at -20
O
C until required for testing. 
Cell Culture Conditions 
Human foreskin fibroblasts (HFF-1) were 
cultured throughout at 37
o
C and 5% CO2 in 
250cm
2
 flasks (Corning B.V. Life Sciences, 
Amsterdam, The Netherlands), in Dulbecco's 
modified eagle medium (DMEM) (Life 
Technologies, Paisley, UK) containing 15% 
foetal bovine serum (FBS), penicillin, 
streptomycin and further supplemented with 6ml 
glutamine. Cultured HFF-1 cells were split 
when fully confluent and trypsinised for 5 
minutes at 37
o
C and 5% CO2. Trypsinisation 
was halted upon addition of 2ml DMEM (15% 
FBS). Prior to any experiment taking place, 
cultured HFF-1 cells were counted and viability 
assessed using the trypan blue exclusion 
method.  
Fibroblast Migration in the Presence of L. 
Sericatanes and nES with Added PI 
A stock solution of 3x10
5 
HFF-1 cells/ml was 
prepared in DMEM 1% FBS. One hundred µl of 
the stock solution were aliquoted into the wells 
of a 24 well plate, supplemented with 400 µl of 
DMEM 1% FCS and incubated at 37
O
C and 5% 
CO2 for 24 hours for the cells to become fully 
confluent and adherent. A 20-200 µl pipette tip 
was used to scratch a “wound” down the centre 
of each well and the media aspirated and 
replaced with either with DMEM 1% FBS 
(vehicle control), 5 µg/ml nES with or without 
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PI in DMEM 1% FBS. The scratch was 
immediately photographed using Zen lite 2011 
software on a Zeiss Axiocam ERc5s camera 
attached to a Zeiss primovert microscope (Carl 
Zeiss LTD. Cambridgeshire, UK) at x200 
magnification to document the size of the 
wound at t0. As this study was only interested in 
the time taken for the wound to close, only the 
later stages of the assay were photographed 
from 12 hours onwards. The plate was then 
incubated for a further 12 hours at 5% CO2 at 
37
O
C before the wells were again photographed 
at x200 magnification at 12, 14 and 16 hours. 
The experiment was stopped after the 16 hour 
time point as, following observation, cells in 
wells exposed to nES with added PI had fully 
closed the wound. Cell migration was measured 
using ImageJ software (national Institutes of 
Health). 
Western Blot Analysis 
As this was an exploratory analysis, nES was 
concentrated by a factor of 10 by centrifugation 
under reduced pressure. Five hundred 
microliters of nES were then retained at a 
concentration of x 10 with dilutions made by 
addition of ultrapure water.  
Maggot nES, at protein concentrations ranging 
from 30 - 3.13 µg/ml were run on 8%, 10%, 
12% or 20% tris-glycine PAGE gels (Bio-Rad 
Laboratories, Hemel Hempstead, UK) 
depending on the size of the protein of interest. 
For TGF-β and VEGF positive controls, lysates 
of the prostate cell lines PC3, LNCaP and PNT2 
cells were prepared in RIPA buffer (Sigma-
Aldrich) as described by the assay protocol. 
Materials for Western blot analysis were 
obtained from the following manufacturers: 
Primary antibodies for TGF-β and VEGF, 
Abcam (Cambridge, UK); recombinant human 
EGF and its primary antibody, R&D systems 
Inc. (Oxon, UK); recombinant human PDGF 
and its primary antibody, Cell Signalling 
technologies (Leiden, The Netherlands); 
recombinant human HGF, EMD Millipore (MA, 
USA) with the primary antibody obtained from 
Abcam; recombinant human FGF and its 
primary antibody, EMD Millipore; secondary 
mouse anti-rabbit-HRP conjugated antibody, 
Cell Signalling technologies; anti β-actin 
antibody, Abcam; secondary rabbit anti-mouse-
HRP conjugated antibodies, Abcam; 
biotinylated molecular weight (MW) ladder and 
antibiotin-HRP conjugated antibody, Cell 
Signalling technologies; rainbow MW ladder, 
Thermo Scientific (Loughborough, UK); 
skimmed milk powder, Sigma-Aldrich. All 
reagents were stored as per the manufacturer’s 
guidelines. For VEGF and TGF-β positive 
controls, protein obtained from the prostate cell 
lines PC3, LnCAP and PNT2 were used since 
these cells secrete TGF-β and VEGF (33-34).  
Positive controls and nES samples, along with 
10 µl of MW ladder were suspended 1:1 in 2x 
concentrated Laemmli sample buffer (10% SDS, 
4 ml; 10% glycerol, 2 ml; 1M Tris-Cl, pH 6.8, 
1.2 ml, β-mercaptoethanol, 1 ml; Milli-Q water, 
1 ml) and spun in a bench top mini-centrifuge 
for 1 minute to mix all sample constituents and 
remove any air bubbles before being heated to 
95
O
C for 5 minutes. All samples along with 10 
µl of rainbow ladder were loaded into the wells 
of an SDS-polyacrylamide gel. Any empty wells 
were filled with loading buffer to promote even 
migration of the proteins and allow any non-
specific binding to be identified. A 4% 
polyacrylamide stacking gel was used 
throughout, with the following polyacrylamide 
resolving gel concentrations being used for each 
assay: EGF, 20%; TGF-β, VEGF and PDGF, 
12%; FGF, 10% HGF, 8%. All gels were run at 
60V through the stacking gel and then 140V 
through the resolving gel. Electrophoresis was 
stopped once the loading front neared the 
bottom of the gel to assure adequate separation 
of the protein bands on the resolving gel. 
Proteins were transferred onto a nitrocellulose 
membrane (Amersham Pharmacia Biotech, 
Amersham, UK). Membranes were blocked for 
30 mins with 5% non-fat dry milk in 1%tween/ 
trid buffered saline to inhibit nonspecific 
binding (all Sigma Aldrich) and incubated 
overnight at 4°C using primary antibodies to, 
HGF (1:1000), FGFb (1:1000), EGF (1:1000), 
PDGF-BB (1:1000), VEGF (1:1000) and TGF-β 
(1:1000). Membranes were washed free of 
primary antibody and incubated with 
horseradish peroxidase conjugated secondary 
anti-mouse/anti-rabbit antibodies (1:1000) for 1 
hour at room temperature. Proteins were 
visualized using the Immun-Star Western 
chemiluminescene detection kit (Bio-Rad) and 
viewed using a Chemidoc XRS system (Bio-
Rad). Western blots were performed at least in 
triplicate. As he VEGF protein in all positive 
control samples was present at the predicted 45 
kDa in all three cell lines. Given that VEGF and 
β-actin are of similar sizes (45 kDa and 41 kDa 
respectively), once VEGF was detected, the 
membrane was re-probed for β-actin. As a 
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result, β-actin was not present in the results. For 
negative controls, one well was filled with 
Laemmli buffer minus maggot secretions, prior 
to electrophoresis.  
Enzyme-Linked Immunosorbent Assay 
(ELISA) 
ELISA kits for human TGF-β1, VEGF, PDGF-
BB, EGF and FGFb were purchased from R&D 
systems (R&D systems, Oxon, UK). Maggot 
lysate was tested to confirm that these growth 
factors were being produced endogenously by L. 
sericata, with three independent batches of nES 
with added PI (concentrated by a factor of 6 to 
achieve a detectable concentration of growth 
factors during ELISA (<4 pg/ml), with the 
exception of PDGF-BB (15 pg/ml)) tested to 
investigate whether these proteins were being 
actively secreted by the maggots. Assays were 
carried out as specified by the assay protocol 
using maggot nES and maggot lysate with added 
PI. For the detection of PDGF-BB and EGF, 
samples were incubated with conjugate for the 
maximum recommended time of 2 hours, 
suggested in the assay protocol. All plates were 
read spectrophotometrically at 450 nm with 
correction at 540 nm. The growth factor 
homologue concentrations detectable in nES 
were then corrected to the mean protein 
concentration of the three batches of nES 
(2519.2 ± 0.1 µg/ml) and expressed as pg/ml. 
STATISTICAL ANALYSIS 
Significance was determined throughout using 
Students two-tailed t-test to compare 
significance with P determined to be significant 
at <0.05, highly significant at <0.005 and very 
highly significant at <0.001. 
RESULTS 
Fibroblast Migration 
Results showed that at all time periods analysed 
(12, 14 and 16 hours) the migration of 
fibroblasts was higher in the presence of 
protease-free nES than in nES or vehicle control 
(figure 1).  For example, 14 hours after 
treatment, fibroblast migration was significantly 
higher in the presence of nES with added PI 
(96.4% ± 1.3%, P<0.001, n = 6) compared to 
the vehicle control (84.4% ± 3.1%, n = 6) and a 
significantly higher (P<0.05) compared to 
fibroblasts to which nES with nES (80.4% ± 
3.0%, n = 6), (Fig. 1). Furthermore, fibroblast 
migration over 16 hours resulted in >95% 
wound closure in five replicates and >98% 
closure in three replicates, significantly greater 
than wound closure in the vehicle control (P 
<0.05). In contrast, fibroblast migration after 16 
hours following treatment with nES only 
increased wound closure to 90.0% ± 3.0% (n 
=6), with only two replicates achieving closure 
of >95%. After 16 hours, there was almost 
complete closure of the wound (96.7%) in the 
presence of protease-free nES (Fig 1), compared 
to 82.7% and 90.0% in the vehicle control and 
nES wounds respectively, although the 
difference between the wound space in 
fibroblasts treated with nES and nES with added 
PI was not significant (P>0.05).  
 
Figure1. Fibroblast migration following treatment with nES and protease-free nES 
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A uniform wound was made in confluent HFF-1 
cells using a 20-200 µl pipette tip and the 
images taken at x200 magnification at 0, 12, 14, 
16 and 18 hours. The wound space was defined 
as the space between the two leading edges of 
fibroblasts, with the whole field of the image 
being measured to ensure consistency between 
samples. The space within the scratch was 
quantified by counting the number of pixels 
highlighted within the space between the two 
populations of fibroblasts. The mean number of 
pixels within the wound space was converted 
into a percentage with the mean number of 
pixels at t0 representing 0% wound closure. 
Percentage of wound closure at 12, 14 and 16 
hours was then calculated as a percentage by 
comparing the number of pixels between the 
two population of fibroblasts at each time point 
to the number of pixels present in the scratch 
within the wound space at time 0. Data 
represents mean closure of the scratch compared 
to the time at t0 ± S.E.M. * = P <0.05, ** = P 
<0.001. n = 6 for all replicates: nES = native 
excretions/secretions; t = time; PI = protease 
inhibitor. 
Growth Factor Homology 
A number of proteins with homology to human 
growth factors were detected in L. sericata nES 
by Western blot analysis. Homologues for TGF-
β and VEGF (Figs 2A and B) were found to be 
present in L. sericata nES at a molecular weight 
approximately 10 kDa lower than human TGF-β 
or VEGF. Conversely, protein homologues of 
EGF and FGF (Figs 2C and D) were detected in 
L. sericata nES at MWs of approximately 25 
kDa and 29 kDa respectively, much larger than 
those of human EGF (6 kDa) and FGF (18 kDa). 
The homologues of human FGF, however, 
appeared to be present at a lower concentration 
than the other growth factors detected, as 
indicated by the fainter bands. Furthermore, 
some faint bands were observed at ~30 kDa and 
~60 kDa. Interestingly, the homologues of 
human PDGF-BB detected were similar in MW 
to that of the recombinant human PDGF protein 
control (Fig. 2 E). However, homologues of 
HGF were not detectable (Fig. 2 F). 
Interestingly, with the exception of Figure2A, 
there appears to be no dose-dependency found 
in the western blots. This could be due to the 
low concentration of proteins present in each of 
the Western blots. 
 
Figure2. Representative Western blots demonstrating the presence of TGF-β (A), VEGF (B), EGF (C), FGF 
(D), PDGF (E) human growth factor homologues and the absence of HGF (F) human growth factor 
homologues in L. Sericata nES.  
Figures 1A, C-F: lane 2, positive control; Lane 3-6 nES (30, 15, 7.5 and 3.75 µg or 25, 12.5, 6.25 and 3.13 µg 
for B). Figures 1B: lane 2-4, positive cell control lysates (PC-3, PNT-2, LnCAP); Lane 5-8 nES. n = >4 for all 
replicates. 
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Human growth factor homologues to TGF-β, 
VEGF, PDGF, FGF and EGF were also 
detectable in both L. sericata lysate (Fig. 3A) 
and in nES (Fig. 3B) by ELISA, confirming the 
finding of Western blot analysis. Following 
quantification in 6x concentrated nES at 
concentrations above the minimum detection 
limit for each assay kit, and correction back to 
original mean protein concentration of the nES 
samples (2519.2 ± 0.1 µg/ml), the mean growth 
factor homologue concentrations per ml of nES 
was found to be; 51.3 ± 5.9 pg/ml (TGF-β2), 
24.9 ± 0.9 pg/ml (VEGF), 2.4 ± 0.7 pg/ml 
(PDGF-BB), 1.8 ± 0.4 pg/ml (FGFb) and 1.0 ± 
0.2 pg/ml (EGF). 
 
 
Figure3. Concentration of human growth factor homologues present in L. sericata lysate and nES 
Luciliasericata lysate (A) and nES (B) were examined using the enzyme linked immunosorbent assay to measure 
the production (lysate) and excretion/secretions (nES) of 5 human growth factor homologues. Data represents 
the mean concentration of human growth factor homologues detected in L. Sericata lysate and nES (pg/ml) with 
n = 6 for each homologue tested. Error bars represent standard error of the mean 
DISCUSSION 
Our investigation has shown that protease-free 
nES was able to significantly enhance fibroblast 
migration. The increase in migration was higher 
than observed for fibroblasts in the presence of 
native secretions containing proteases. Previous 
in vitro investigations attributed the enhanced 
fibroblast migration to endogenous maggot 
proteases (20-22), and whilst this has been 
partially confirmed in this study, as nES 
(without proteases inhibitors added) was able to 
significantly enhance fibroblast migration above 
the vehicle control, our results suggest that 
maggot-enhanced fibroblast migration may be 
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due to some other or additional molecules 
present in larval secretions. 
Investigating this further, we found that Western 
blot analysis using monoclonal antibodies, with 
no other species cross reactivity, revealed the 
presence of molecules with homology to human 
growth factors FGF, TGF-β, VEGF, EGF and 
PDGF-BB, growth factors integral to the wound 
healing process. The enzyme-linked 
immunosorbent assay confirmed our findings of 
the Western blot analysis and demonstrated that 
L. sericatalarvae are able to produce and secrete 
proteins, homologous to TGF-β2, VEGF, 
PDGF, FGF and EGF. 
The L. sericata FGF homologue was detected in 
L. sericata nES by both ELISA and Western 
blot analysis, although at a different MW to that 
of human FGF. Differences in MW between 
growth factors in humans and insects are 
however well documented in FGF (35): 
Fibroblast growth factor specifically in humans 
varies from 17 – 34 kDa, but is present as the 84 
kDa protein branchless (Bnl) in D. 
Melanogaster (35) with these proteins being 
structurally similar to one another (36). All 
members of the FGF family have also been 
shown to share a conserved amino acid 
sequence of 120 residues that express 16% - 
65% identity (35). Three FGF genes have also 
been detected in D. melanogaster  and two in 
Caenorhabditiselegans (37) (genes elg-17(38) 
and let-756(39) which encode for an FGF-like 
ligand). It may therefore be likely that human 
FGF homologues are present in L. sericatanES. 
Furthermore, as FGF has been found to be 
essential for D. melanogaster development, but 
is structurally similar to vertebrate FGFs (36), it 
may also play a significant role in L. sericata 
development. 
Transforming growth factor-β (TGF-β) 
homologues have also been detected in 
invertebrates. Members of the Bone 
Morphogenic Protein (BMP) super family of 
proteins for example are also present in D. 
melanogaster, including Dpp, 60A and screw 
(40). Furthermore, 60A in D. melanogaster 
shows greater homology to human BMP 5, 6 
and 7 than to Dpp (41). Members of the TGF-β 
family have also been described in other 
invertebrates including sea urchins (42). 
Considering its abundance in both vertebrates 
and invertebrates (notably D. melanogaster), it 
may be that the protein homologue for human 
TGF-β detected in this investigation was L. 
sericata TGF-β, which appears to show 
homology to H. sapiens TGF-β, but has a 
different molecular weight. Lucilia sericata 
TGF-β did also appear to be present at a 
relatively higher concentration than other 
proteins analysed. This may suggest that L. 
sericata TGF-β plays an important role in larval 
growth and/or development, as it does in D. 
melanogaster development (43).  
The VEGF homologue detected in L. sericata 
nES was found to be approximately 10 kDa 
smaller than human VEGF, suggesting that a 
protein present within L. sericata nES shares 
homology with human VEGF. A number of 
VEGF proteins and VEGF receptors with 
homology to human VEGF proteins and 
receptors have been reported in D. 
melanogaster, with predicted signal peptide and 
central domains which are common to VEGF 
super family members (44). These include a 
VEGF receptor with homology to human VEGF 
receptor Pvr, which has been demonstrated in D. 
melanogaster gene GC8222 (cytological region 
29A), with predicted signal peptide and central 
domains which are common to VEGF super 
family members (38). Caenorhabditis elegans 
PDGF/VEGF-1 has also been shown to bind and 
activate human VEGF receptors -1 and -2 in 
human umbilical vein endothelial cells inducing 
angiogenic responses (45). This evidence again 
supports the hypothesis that the proteins 
detected in L. sericata nES may be homologous 
to human growth factors and able to elicit a 
response in human cells.  
The presence of EGF and PDGF-BB 
homologues in L. sericatanESIs also supported 
by the presence of these proteins in the D. 
melanogaster genome (44), including the EGF 
homologue genes Notch and Delta (Dl) (46). 
The results do appear to suggest that maggots 
produce proteins homologous to human EGF 
and PDGF-BB. However, no proteins 
homologues to human HGF were detected in L. 
sericata nES and no literature is available on the 
presence of HGF in insects.  It may be that HGF 
plays no functional role in insect development 
was therefore not present within L. sericata 
nES. 
In conclusion, this study has shown, upon 
inhibition of their endogenous proteases, L. 
sericata larval nES are still able to stimulate 
fibroblast migration, to a greater extent than 
nES with proteases, which were originally 
thought to be the main promoters of fibroblast 
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migration in vitro. We suggest that the increase 
in fibroblast migration may, in part, be due to 
the presence of other proteins, possibly growth 
factor-like proteins that we have detected for the 
first time in maggot secretions, and which show 
homology to five human growth factors. Further 
investigations are now required to determine 
what concentrations of these growth factors are 
secreted into the wound during MT and how the 
concentration of growth factors secreted in the 
wound are able to affect fibroblast, keratinocyte 
proliferation and migrations, as well as any 
effect on angiogenesis. 
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